Gene · 654
Papers3,545
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,545
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mucin 1 Inhibits Ferroptosis and Sensitizes Vitamin E to Alleviate Sepsis-Induced Acute Lung Injury through GSK3β/Keap1-Nrf2-GPX4 Pathway. | Oxid Med Cell Longev | 2022 | 35910848 | PubTator, text mining | PubMed |
| Focusing on OB-OC-MΦ Axis and miR-23a to Explore the Pathogenesis and Treatment Strategy of Osteoporosis. | Front Endocrinol (Lausanne) | 2022 | 35909545 | PubTator, text mining | PubMed |
| Growing Pains: The Need for Engineered Platforms to Study Growth Plate Biology. | Adv Healthc Mater | 2022 | 35905390 | PubTator, text mining | PubMed |
| Clinical application of mesenchymal stem cell in regenerative medicine: a narrative review. | Stem Cell Res Ther | 2022 | 35902958 | PubTator, text mining | PubMed |
| Effects of Cyclosporine A and Adalimumab on the expression profiles histaminergic system-associated genes and microRNAs regulating these genes in HaCaT cells. | Cell Cycle | 2022 | 35899934 | PubTator, text mining | PubMed |
| Paracrine Factors Released by Stem Cells of Mesenchymal Origin and their Effects in Cardiovascular Disease: A Systematic Review of Pre-clinical Studies. | Stem Cell Rev Rep | 2022 | 35896860 | PubTator, text mining | PubMed |
| Identification of candidate enhancers controlling the transcriptome during the formation of interphalangeal joints. | Sci Rep | 2022 | 35896673 | PubTator, text mining | PubMed |
| Immunomodulation Effect of Biomaterials on Bone Formation. | J Funct Biomater | 2022 | 35893471 | PubTator, text mining | PubMed |
| Vitamin A in Skin and Hair: An Update. | Nutrients | 2022 | 35889909 | PubTator, text mining | PubMed |
| Caffeine Decreases Hepcidin Expression to Alleviate Aberrant Iron Metabolism under Inflammation by Regulating the IL-6/STAT3 Pathway. | Life (Basel) | 2022 | 35888113 | PubTator, text mining | PubMed |
| Emerging Roles of the Iron Chelators in Inflammation. | Int J Mol Sci | 2022 | 35887336 | PubTator, text mining | PubMed |
| Effects of Super-Activated Platelet Lysate on Early Healing of Tooth Extraction Sockets in Rats. | Drug Des Devel Ther | 2022 | 35860524 | PubTator, text mining | PubMed |
| Bone remodeling: an operational process ensuring survival and bone mechanical competence. | Bone Res | 2022 | 35851054 | PubTator, text mining | PubMed |
| Automated Fabrication of Streptavidin-Based Self-assembled Materials for High-Content Analysis of Cellular Response to Growth Factors. | ACS Appl Mater Interfaces | 2022 | 35849638 | PubTator, text mining | PubMed |
| From Transcriptomics, Metabolomics to Functional Studies: Extracellular ATP Induces TGF-β-Like Epithelial Mesenchymal Transition in Lung Cancer Cells. | Front Oncol | 2022 | 35847855 | PubTator, text mining | PubMed |
| Dominant Myocardial Fibrosis and Complex Immune Microenvironment Jointly Shape the Pathogenesis of Arrhythmogenic Right Ventricular Cardiomyopathy. | Front Cardiovasc Med | 2022 | 35845067 | PubTator, text mining | PubMed |
| Multi-Omics Analysis and Machine Learning Prediction Model for Pregnancy Outcomes After Intracytoplasmic Sperm Injection-in vitro Fertilization. | Front Public Health | 2022 | 35844885 | PubTator, text mining | PubMed |
| Transcriptional profiles predict treatment outcome in patients with tuberculosis and diabetes at diagnosis and at two weeks after initiation of anti-tuberculosis treatment. | EBioMedicine | 2022 | 35841871 | PubTator, text mining | PubMed |
| Iron-Induced Hepatocarcinogenesis-Preventive Effects of Nutrients. | Front Oncol | 2022 | 35832553 | PubTator, text mining | PubMed |
| Alternative B Cell Differentiation During Infection and Inflammation. | Front Immunol | 2022 | 35812395 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/654/papers?page=33